Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2016
Same author

Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.

JACC. Cardiovascular interventions·2016
Same author

Long-term clinical impact of polymer-free sirolimus-eluting stents in unselected patients.

Coronary artery disease·2016
Same author

Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.

JACC. Cardiovascular interventions·2016
Same author

Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Circulation. Cardiovascular imaging·2016
Same author

High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease.

VASA. Zeitschrift fur Gefasskrankheiten·2016

相关实验视频

Updated: May 11, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

在急性心肌梗塞患者治疗冠状动脉支架或血栓溶解的患者中,治疗时间间隔对心肌挽救的治疗依赖的影响.

Albert Schömig1, Gjin Ndrepepa, Julinda Mehilli

  • 1Deutsches Herzzentrum and 1. Medizinische Klinik rechts der Isar, München, Germany. aschoemig@dhm.mhn.de

Circulation
|August 20, 2003
PubMed
概括

在急性心肌梗塞 (AMI) 患者中,冠状动脉支架保留了比血栓溶解更多的心肌. 与血栓溶解相比,支架的好处随着治疗时间的延长而增加.

更多相关视频

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

相关实验视频

Last Updated: May 11, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

科学领域:

  • 心脏病学 心脏病学
  • 干预心脏病学 干预心脏病学
  • 急性心肌梗塞研究研究

背景情况:

  • 治疗延迟对接受再注射治疗的急性心肌梗塞 (AMI) 患者心肌梗塞挽救的影响尚不清楚.
  • 调查治疗时间和心肌救援之间的关系对于优化AMI患者的治疗结果至关重要.

研究的目的:

  • 评估治疗时间间隔对AMI患者心肌梗塞挽救的影响.
  • 为了比较冠状动脉支架与血栓溶解在保护心肌组织的有效性,跨越不同的治疗延迟时间.

主要方法:

  • 来自两项随机试验的264名AMI患者的分析,随机分为冠状动脉支架 (133) 或血栓溶解 (131).
  • 根据治疗时间的间隔,患者被分为三组:<165分钟,165-280分钟和>280分钟.
  • 心肌挽救指数通过配对的光束检查作为主要终点来确定.

主要成果:

  • 血栓溶解显示,随着治疗时间的延长 (P=0.03),救援指数下降 (P=0.03).
  • 冠状动脉支架在所有时间间隔中都表现出一致的救援指数 (P=0.59).
  • 支架产生显著更高的心肌救援比血栓溶解,特别是在长时间的治疗延迟 (P<0.0005).

结论:

  • 对于AMI中心肌梗塞救援的再注射疗法的有效性取决于所选择的方法.
  • 冠状动脉支架在保护心肌组织方面优于血栓溶解,无论治疗延迟如何.
  • 支架在血栓溶解上的优势变得越来越明显,因为症状出现的时间越来越长.